Generalist Cohort of Migrant Patients Consultants in City Medicine
NCT ID: NCT04989426
Last Updated: 2024-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
197 participants
OBSERVATIONAL
2021-11-25
2023-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Care Access for Asylum Seekers in Brittany : Description, Associated Factors and Levers of Improvement
NCT03754374
Qualitative Study Among Migrant and Socially Vulnerable Populations on Their Interest in Collective Approaches to Health Promotion.
NCT07174154
Access to Healthcare and the Right to Health of People Living in Disadvantaged Neighborhoods Around Cayenne in French Guiana
NCT03359707
Creation of a PBRN to Study Healthcare Delivery to a Transitioning Community
NCT00503555
Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
NCT03697772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The health data comes from the participant's care file and some social data is extracted from the social information system, already existing and used by the reception agents responsible for the consultations. access to rights.
Inclusion visit :
This visit will take place during the first medical visit of eligible patients.
During this visit, the investigative team:
* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations.
Follow-up visits Follow-up will be continued 12 months after the inclusion visit. The rhythm, as well as the nature of the follow-up visits for the patients included, will be defined by the information obtained during the inclusion visit, and will be determined by the doctor in charge of the patient.
For patients included retrospectively The inclusion visit will take place during a follow-up medico-social visit planned as part of the care in one of the participating the municipal health center.
During this visit, the investigative team:
* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations
During the inclusion visit and medical follow-up visits, within the Municipal Health Centers, a consultation on access to rights will also be carried out in order to help patients put together their social file.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the state of health of newly arrived migrant patients in the year following their arrival in France
the state of health of newly arrived migrant patients in the year following their arrival in France
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly arrived migrants (foreigners born outside France, first arrival in France AND presence in the territory ≤ 1 year)
* 1st medical contact in town medicine in France
Exclusion Criteria
* Communication impossible due to the language barrier despite translation or interpreting (telephone or face-to-face)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMS Aubervilliers
Aubervilliers, , France
CMS Saint-Denis
Saint-Denis, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP210936
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.